date:Nov 05, 2012
selective technology, called EFLAHyperPure, to ensure that finished extracts fulfil these requirements. Utilised successfully in Frutarom's pharma grade plant in Wdenswil, Switzerland, the first U.S.-based run will be completed this month.
HyperPure technology has, according to the company, been proven safe and effective. It utilises a specially designed cross flow membrane microfiltration process to separate unwanted lipophilic compounds. Stable, pure and active extracts are obtained without u